Perspective Therapeutics (CATX) Long-Term Debt Repayments (2010 - 2026)
Perspective Therapeutics' Long-Term Debt Repayments came in at $13,000 for Q2 2026, unchanged from $13,000 a year earlier and down 13.3% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Long-Term Debt Repayments (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Perspective Therapeutics reported Long-Term Debt Repayments of $54,000, unchanged year-over-year; for FY2025, it came in at $52,000, up 8.3% from FY2024.
- Going back by year, Long-Term Debt Repayments was $48,000 in FY2024 (-29.4%) and $68,000 in FY2023.
- The five-year range for quarterly Long-Term Debt Repayments is $8,000 (Q2 2024) to $21,000 (Q3 2023).
- Year-over-year, Long-Term Debt Repayments increased in four of the last eight quarters, with growth averaging 6.5%.
- The fastest year-over-year change in Long-Term Debt Repayments over five years came in Q2 2025 (growth of 62.5%), and the weakest in Q2 2024 (a decline of 60.0%).
- Business Quant data shows CATX's Long-Term Debt Repayments at $15,000 (Q1 2026), $13,000 (Q4 2025) and $13,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -4.91 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.05 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 19.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Perspective Therapeutics | 104.44 Mn | -132.46 Mn | - | 13,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Jun 30, 2011 | 141,661.00 |
| Mar 31, 2011 | 13,001.00 |
| Dec 31, 2010 | 13,414.00 |
| Sep 30, 2010 | 11,919.00 |
API Access
Perspective Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();